Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies. [electronic resource] by
- Webber, S
- Bartlett, C A
- Boritzki, T J
- Hillard, J A
- Howland, E F
- Johnston, A L
- Kosa, M
- Margosiak, S A
- Morse, C A
- Shetty, B V
Producer: 19960606
In:
Cancer chemotherapy and pharmacology vol. 37
Availability: No items available.
|
|
|
12.
|
Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors. [electronic resource] by
- Koda, R T
- Garcia, A A
- Chatterjee, D J
- Li, W Y
- Parimoo, D
- Jeffers, S
- Rogers, M
- Leichman, C G
- Leichman, L
- Wu, E Y
- Shetty, B V
- Webber, S
- Clendinnin, N
- Muggia, F M
Producer: 19990520
In:
Cancer chemotherapy and pharmacology vol. 43
Availability: No items available.
|
|
|
13.
|
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. [electronic resource] by
- Kaldor, S W
- Kalish, V J
- Davies, J F
- Shetty, B V
- Fritz, J E
- Appelt, K
- Burgess, J A
- Campanale, K M
- Chirgadze, N Y
- Clawson, D K
- Dressman, B A
- Hatch, S D
- Khalil, D A
- Kosa, M B
- Lubbehusen, P P
- Muesing, M A
- Patick, A K
- Reich, S H
- Su, K S
- Tatlock, J H
Producer: 19980112
In:
Journal of medicinal chemistry vol. 40
Availability: No items available.
|